News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,707 Results
Type
Article (87421)
Company Profile (760)
Press Release (772504)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233052)
Career Advice (4139)
Deals (39795)
Drug Delivery (136)
Drug Development (91246)
Employer Resources (203)
FDA (18279)
Job Trends (17399)
News (397380)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (236)
Approvals (18295)
Artificial intelligence (486)
Autoimmune disease (72)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (159)
Biotechnology (484)
Bladder cancer (125)
Brain cancer (52)
Breast cancer (484)
Cancer (3882)
Cardiovascular disease (338)
Career advice (3556)
Career pathing (38)
CAR-T (245)
CDC (57)
Cell therapy (681)
Cervical cancer (32)
Clinical research (75407)
Collaboration (1377)
Company closure (4)
Compensation (934)
Complete response letters (59)
COVID-19 (2956)
CRISPR (81)
C-suite (585)
Cystic fibrosis (134)
Data (4371)
Decentralized trials (2)
Denatured (61)
Depression (110)
Diabetes (451)
Diagnostics (7091)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (230)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (98790)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132921)
Executive appointments (987)
FDA (20718)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1250)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1018)
Government (5384)
Grass and pollen (7)
Guidances (339)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (56)
Immunology and inflammation (240)
Immuno-oncology (20)
Indications (53)
Infectious disease (3192)
Inflammatory bowel disease (186)
Inflation Reduction Act (15)
Influenza (96)
Intellectual property (187)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (15)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (555)
Lymphoma (264)
Machine learning (29)
Management (66)
Manufacturing (635)
MASH (138)
Medical device (14869)
Medtech (14892)
Mergers & acquisitions (22740)
Metabolic disorders (1150)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2710)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (556)
Opinion (311)
Ovarian cancer (133)
Pain (164)
Pancreatic cancer (170)
Parkinson's disease (242)
Partnered (30)
Patents (416)
Patient recruitment (309)
Peanut (57)
People (66248)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23257)
Phase II (32736)
Phase III (24643)
Pipeline (2702)
Policy (295)
Postmarket research (3554)
Preclinical (10494)
Press Release (72)
Prostate cancer (198)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (666)
Real estate (7421)
Recruiting (78)
Regulatory (27982)
Reports (65)
Research institute (2688)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1040)
Venture capital (66)
Weight loss (395)
Women's health (58)
Worklife (21)
Date
Today (32)
Last 7 days (593)
Last 30 days (2298)
Last 365 days (33385)
2025 (26243)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50956)
Australia (8955)
California (9396)
Canada (2852)
China (892)
Colorado (400)
Connecticut (420)
Delaware (264)
Europe (117071)
Florida (1388)
Georgia (315)
Hawaii (3)
Idaho (67)
Illinois (810)
India (51)
Indiana (459)
Iowa (19)
Japan (318)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1274)
Massachusetts (7085)
Michigan (313)
Minnesota (560)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (107)
New Hampshire (77)
New Jersey (2610)
New Mexico (32)
New York (2564)
North Carolina (1409)
North Dakota (10)
Northern California (4236)
Ohio (295)
Oklahoma (22)
Oregon (50)
Pennsylvania (1961)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3595)
Tennessee (149)
Texas (1475)
United States (34807)
Utah (282)
Virginia (248)
Washington D.C. (83)
Washington State (814)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,707 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
October 19, 2025
·
19 min read
Press Releases
Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma
October 19, 2025
·
9 min read
Press Releases
Tubulis Presents First Clinical Data from Phase I/IIa Trial for TUB-040 in Platinum-Resistant Ovarian Cancer (PROC) at ESMO 2025
October 19, 2025
·
6 min read
Press Releases
XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer
October 19, 2025
·
19 min read
Press Releases
Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025
October 19, 2025
·
5 min read
Press Releases
ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy
October 19, 2025
·
4 min read
Press Releases
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment
October 19, 2025
·
7 min read
Press Releases
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
October 19, 2025
·
3 min read
Press Releases
Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025
October 19, 2025
·
5 min read
Press Releases
SystImmune Announces iza-bren Meets One of the Dual Primary Endpoints in the BL-B01D1-303 Trial in Recurrent or Metastatic NPC Patients with Results Presented as a Late-Breaking Oral Presentation at ESMO
October 19, 2025
·
6 min read
1 of 86,071
Next
